Anna Feygina is a Senior Medical Liaison for Neuromodulation in the Asia-Pacific region at LivaNova in Singapore. She uses her medical background as a neurologist to aid LivaNova in increasing awareness about drug-resistant epilepsy, non-pharmacological treatments, and VNS Therapy among healthcare professionals, patients, and their families. She has been with the company since August 2018.
Q: What led you to a career in medtech?
A: The medtech field allows me to continue my journey in science and medicine, while expanding into marketing, communication, and presentation skills. I get to use my medical expertise to provide my colleagues with specific, relevant data that assists them in resolving issues and finding answers.